Skip to main content

Symposia 11 - WHO System for Reporting Lymph Node and Spleen Cytopathology Slide Seminar

Tracking # 20-1038418

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

This slide seminar will discuss examples from all different diagnostic categories included in the WHO International System for Reporting Lymph Node and Spleen Cytopathology. Morphological approach, ancillary study selection, and reporting format for each category will be addressed in this slide seminar.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1.5h General (Cytology)

Clinical Laboratory Supervisor

1.5h General (Cytology)

Clinical Laboratory Technician

1.5h General (Cytology)

Clinical Laboratory Technologist

1.5h General (Cytology)

Public Health Director

1.5h General (Cytology)

Public Health Supervisor

1.5h General (Cytology)

Public Health Technologist

1.5h General (Cytology)

Disclosure statements

The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:

Michael Berry, SCT(ASCP)MBCM: Stockholder-Hologic

Ruth Katz, MD: Research Support - Cynvenio

Oscar Lin, MD, PhD: Consultant – Hologic and Jansen

Liron Pantanowitz, MD: Consultant – Hamamatsu, Advisory Board for Ibex

Martha B. Pitman, MD, FIAC: Consultant – Adenocyte, LLC

Donna K. Russell, MEd, CT(ASCP), HT(ASCP): Advisory Board – Hologic Scientific

Christopher J. VandenBussche, MD, PhD: Ad hoc advisory board panel and Consultant – Roche

Paul VanderLaan, MD, PhD: Consultant – Gala Therapeutics